NDC 68001-668 – Aprepitant
Aprepitant 125 mg/1 · Capsule · Oral
Product NDC68001-668
Product details
- Brand name
- Aprepitant
- Generic name
- Aprepitant
- Labeler
- BluePoint Laboratories
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA207777
- Marketed since
- February 10, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Substance P/Neurokinin-1 Receptor Antagonist
Active ingredients
- Aprepitant 125 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 68001-668-19 | 1 BLISTER PACK in 1 CARTON (68001-668-19) / 6 CAPSULE in 1 BLISTER PACK (68001-668-44) | Feb 10, 2026 |
Other Aprepitant products
- 68001-667 Aprepitant 80 mg/1 · Capsule · BluePoint Laboratories
- 68001-666 Aprepitant 40 mg/1 · Capsule · BluePoint Laboratories
- 68462-585 Aprepitant 125 mg/1 · Capsule · Glenmark Pharmaceuticals Inc., USA
- 68462-584 Aprepitant 80 mg/1 · Capsule · Glenmark Pharmaceuticals Inc., USA
- 68462-583 Aprepitant 40 mg/1 · Capsule · Glenmark Pharmaceuticals Inc., USA
- 51407-702 Aprepitant 80 mg/1 · Capsule · Golden State Medical Supply, Inc.
- 51407-703 Aprepitant 125 mg/1 · Capsule · Golden State Medical Supply, Inc.
- 51407-701 Aprepitant 40 mg/1 · Capsule · Golden State Medical Supply, Inc.
- 0781-2321 Aprepitant 40 mg/1 · Capsule · Sandoz Inc
- 0781-2323 Aprepitant 125 mg/1 · Capsule · Sandoz Inc
- 0781-2322 Aprepitant 80 mg/1 · Capsule · Sandoz Inc
- 13668-593 Aprepitant 125 mg/1 · Capsule · Torrent Pharmaceuticals Limited